Autism Study Finds Significant Benefit With Hyperbaric Treatment
A new autism study gives help to autistic children. Physician Daniel Rossignol, M.D., treats children with autism. He has treated his patients with hyperbaric oxygen treatment with good results. With this background, he conducted the first large scale, double-blind, controlled study to examine its effectiveness.
Hyperbaric therapy traditionally involves inhaling up to 100% oxygen at a pressure greater than 1 atmosphere (atm) in a pressurized chamber. Dr. Rossignol and colleagues studied 62 children, aged 2-7 years, to assess the efficacy of hyperbaric treatment in children with autism.Their results show that children with autism who received hyperbaric treatment at 1.3 atmospheres and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.
The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atm and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atm and 21% oxygen (non-treatment group). Dr. Rossignol said, "In our study, we observed significant improvements in several core autistic behaviors with the use of hyperbaric therapy at 1.3 atm compared to children receiving near-placebo treatment.
These findings confirm what we are seeing in clinical practice--that many children with autism may benefit with the use of this treatment."Director of the International Hyperbarics Association, Shannon Kenitz, said, "With autism on the rise, it is promising to see a study that has been conducted with the high standards endorsed by the medical community.
Having this scientifically controlled and analyzed study that shows the positive effects of hyperbarics is truly what this community has needed. The study not only presents the benefit of Hyperbaric Oxygen Therapy for children with autism, but also gives families the hope that so many other therapies have failed to do."Autism specialist Kyle Van Dyke commemted, "The impact of this study on the autism community is significant. It brings validity to a successful intervention that needs to become part of mainstream medicine.”
This article is very good news for those with autism. This is one of the most promising studies in the recent development of treatment.
http://www.medicalnewstoday.com/articles/143740.php
Hyperbaric therapy traditionally involves inhaling up to 100% oxygen at a pressure greater than 1 atmosphere (atm) in a pressurized chamber. Dr. Rossignol and colleagues studied 62 children, aged 2-7 years, to assess the efficacy of hyperbaric treatment in children with autism.Their results show that children with autism who received hyperbaric treatment at 1.3 atmospheres and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.
The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atm and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atm and 21% oxygen (non-treatment group). Dr. Rossignol said, "In our study, we observed significant improvements in several core autistic behaviors with the use of hyperbaric therapy at 1.3 atm compared to children receiving near-placebo treatment.
These findings confirm what we are seeing in clinical practice--that many children with autism may benefit with the use of this treatment."Director of the International Hyperbarics Association, Shannon Kenitz, said, "With autism on the rise, it is promising to see a study that has been conducted with the high standards endorsed by the medical community.
Having this scientifically controlled and analyzed study that shows the positive effects of hyperbarics is truly what this community has needed. The study not only presents the benefit of Hyperbaric Oxygen Therapy for children with autism, but also gives families the hope that so many other therapies have failed to do."Autism specialist Kyle Van Dyke commemted, "The impact of this study on the autism community is significant. It brings validity to a successful intervention that needs to become part of mainstream medicine.”
This article is very good news for those with autism. This is one of the most promising studies in the recent development of treatment.
http://www.medicalnewstoday.com/articles/143740.php
posted by Amber Thrapp at 8:03 PM
0 Comments:
Post a Comment
<< Home